Innate Pharma S.A. (EPA:IPH)
France · Delayed Price · Currency is EUR 1.776
-0.018 (-1.00%)
Oct 21, 2025, 10:40 AM CET
Innate Pharma Market Cap
Innate Pharma has a market cap or net worth of €165.35 million as of October 20, 2025. Its market cap has increased by 6.16% in one year.
Market Cap
165.35M
Enterprise Value
132.35M
Revenue
12.64M
Ranking
n/a
PE Ratio
n/a
Stock Price
€1.78
Market Cap Chart
Since November 1, 2006, Innate Pharma's market cap has increased from 792.12K to 165.35M, an increase of 20,774.04%. That is a compound annual growth rate of 32.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 20, 2025 | 165.35M | 3.38% |
| Dec 31, 2024 | 159.94M | -24.29% |
| Dec 29, 2023 | 211.24M | -19.93% |
| Dec 30, 2022 | 263.84M | -24.98% |
| Dec 31, 2021 | 351.67M | 28.64% |
| Dec 31, 2020 | 273.37M | -41.60% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EssilorLuxottica Société anonyme | 144.11B |
| Sanofi | 105.17B |
| Sartorius Stedim Biotech | 19.71B |
| bioMérieux | 13.02B |
| Eurofins Scientific SE | 11.09B |
| Ipsen | 9.40B |
| ABIVAX Société Anonyme | 5.93B |
| Virbac | 2.79B |